GSK, AstraZeneca Settle Contract Dispute for Pharma Head

Source: Reuters

Jun 20, 2017

GlaxoSmithKline has made a deal for Luke Miels to start as its head of pharmaceuticals in September, following a dispute over his contract with AstraZeneca. 

Miels was poached by GSK in January but was unable to officially join after AstraZeneca filed a lawsuit. The agreement avoids the need for a court case over the contract.

GSK was planning for Miels to work alongside outgoing pharma head Abbas Hussain, but this dispute has made that reality impossible.

Miels brings both commercial and scientific experience after working at AstraZeneca, Roche and Sanofi.

Read the Reuters report

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments